Type 2 Diabetes Mellitus
Conditions
Keywords
prevention, health services research
Brief summary
Patients with type-2 diabetes mellitus have an higher risk developing secondary disorders. In an epidemiological longitudinal study of about 1.150 patients with type 2 diabetes mellitus we investigate determinants and predictors for long-term prognosis. The patients are recruited and supervised in practices of general practitioners of the administrative district of Ludwigsburg/Heilbronn (Baden-Württemberg, Germany). In a subgroup of about 200 patients with a dissatisfactory metabolic status (HbA1c \> 7,5%) a randomised interventional study is performed. The intervention comprises a telephone counseling by the medical secretary of each practice executed in a predefined period of time. The outcome parameters of interest are the change of HbA1c, the development of secondary disorders and adverse events, quality of life and risk factor control, as well as hospitalization and mortality. The aim of the study was to develop an patient-centred instrument implementable in the routine medical care in order to enhance the prognosis of patients with type-2 diabetes mellitus.
Interventions
OTHERTelephone counseling
Telephone counseling is provided once a month by the medical secretary of the general practitioner's practices
Sponsors
Heidelberg University
German Federal Ministry of Education and Research
German Cancer Research Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient with type-2 diabetes mellitus attending the general practitioner's in the time from October to December 2008 * Ability to take part in the study
Exclusion criteria
* Nursing home resident * Insufficient knowledge of the German language * Palliative health care with limited life expectancy * Emergency outpatient * All outpatients who attend the general practitioner by way of exception
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c | 18 months |
Secondary
| Measure | Time frame |
|---|---|
| CHD, mortality | 18 months |
| lipid metabolism control | 18 months |
| hospitalization | 18 month |
| health-related quality of life | 18 months |
| incidence of diabetes-related complications | 18 months |
| risk factor control (eg. body weight, physical activity, smoking) | 18 months |
Countries
Germany
Outcome results
None listed